← Back to pipeline
Interventional oncology
Localised oncology delivery device
A device-delivered depot that concentrates cytotoxic therapy at the tumour site during an interventional procedure.
Development stage
- Discovery
- Preclinical
- Clinical
- Regulatory review
- Marketed
- Indication
- Solid tumour adjunct therapy
About the programme
Delivers dose where the interventionalist is already working, limiting systemic exposure and the toxicity that comes with it.
Release profile is designed to persist across the days following the procedure rather than washing out immediately.